Literature DB >> 16997600

Posterior spinal epidural abscess: an unusual complication of vertebroplasty.

Yetkin Söyüncü1, Hakan Ozdemir, Seçgin Söyüncü, Zekiye Bigat, Semih Gür.   

Abstract

OBJECTIVE: Complications after vertebroplasty are rare. There are few reported infectious complications requiring surgical management such as corpectomy with anterior reconstruction and posterior stabilization, although we have not seen any reports about epidural abscess in the literature. We present a patient in whom posterior epidural abscess developed after vertebroplasty in which drainage and antibiotherapy were required for treatment.
METHODS: A 70-year-old female with a painful T12 osteoporotic compression fracture underwent percutaneous vertebroplasty using polymethylmethacrylate without complication. One week after vertebroplasty, however, she had fever and increased back pain. On clinical examination, soft tissue abscess formation was determined at the vertebroplasty site. This was drained surgically and antibiotic treatment was started. At follow-up, she had progressive neurological deterioration (paraparetic) on the 18th day after abscess drainage. MRI of the thoracolombar spine revealed posterior spinal epidural abscess at the T11/12 level. Partial laminectomy and drainage were performed. She had complete neurological recovery in the follow-up period.
CONCLUSION: An epidural abscess, which is an unusual complication of vertebroplasty, represents a medical and surgical emergency. Treatment is generally urgent surgical drainage combined with antibiotics. The patient should be evaluated in detail for systemic infectious disease and comorbid conditions before the vertebroplasty procedure.

Entities:  

Mesh:

Year:  2006        PMID: 16997600     DOI: 10.1016/j.jbspin.2006.01.015

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  8 in total

1.  Kyphoplasty.

Authors:  David M Kasper
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

2.  CT-guided vertebroplasty: analysis of technical results, extraosseous cement leakages, and complications in 500 procedures.

Authors:  Michael Bernhard Pitton; Sascha Herber; Ulrike Koch; Katja Oberholzer; Philip Drees; Christoph Düber
Journal:  Eur Radiol       Date:  2008-06-04       Impact factor: 5.315

Review 3.  Percutaneous vertebroplasty in tumoral osteolysis.

Authors:  T F Jakobs; C Trumm; M Reiser; R T Hoffmann
Journal:  Eur Radiol       Date:  2007-02-03       Impact factor: 7.034

4.  Surgical outcomes of infectious spondylitis after vertebroplasty, and comparisons between pyogenic and tuberculosis.

Authors:  Jen-Chung Liao; Po-Liang Lai; Lih-Hui Chen; Chi-Chien Niu
Journal:  BMC Infect Dis       Date:  2018-11-12       Impact factor: 3.090

5.  Vertebral augmentation-related Clostridium septicum osteomyelitis.

Authors:  Nicholas Pavlatos; Matthew Kurian; Omar Khan; Allen Guehl; Feras Deek; Azim Shaikh; Mubin I Syed
Journal:  Radiol Case Rep       Date:  2022-08-05

6.  Simultaneous-onset infectious spondylitis with vertebral fracture mimicking an acute osteoporotic vertebral fracture erroneously treated with balloon kyphoplasty: illustrative case.

Authors:  Noritaka Yonezawa; Yuji Tokuumi; Nobuhiko Komine; Takaaki Uto; Yasumitsu Toribatake; Hideki Murakami; Satoru Demura; Hiroyuki Tsuchiya
Journal:  J Neurosurg Case Lessons       Date:  2021-09-20

7.  Risk factors for tuberculous or nontuberculous spondylitis after percutaneous vertebroplasty or kyphoplasty in patients with osteoporotic vertebral compression fracture: A case-control study.

Authors:  Bo-Wen Zheng; Fu-Sheng Liu; Bo-Yv Zheng; Hua-Qing Niu; Jing Li; Guo-Hua Lv; Ming-Xiang Zou; Zhun Xu
Journal:  Front Surg       Date:  2022-08-18

8.  Debridement and corpectomy via single posterior approach to treat pyogenic spondylitis after vertebral augmentation.

Authors:  Shuai Zhang; Jin Yang; Song Wang; Qing Wang; Shuang Xu
Journal:  BMC Musculoskelet Disord       Date:  2021-06-26       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.